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Objective: The objectives of this study were to analyze efficacy of immature and mature mouse oocytes after vitrification and warming by ap-
plying various combinations of cryoprotectants (CPAs) and/or super-rapid cooling using slush nitrogen (SN2). 
Methods: Four-week old ICR female mice were superovulated for GV- and MII-stage oocytes. Experimental groups were divided into two groups. 
Ethylene glycol (EG) only group: pre-equilibrated with 1.5 M EG for 2.5 minutes and then equilibrated with 5.5 M EG and 1.0 M sucrose for 20 
seconds. EG+dime thylsulfoxide (DMSO) group: pre-equilibrated with 1.3 M EG+1.1 M DMSO for 2.5 minutes and equilibrated with 2.7 M EG+  
2.1 M DMSO+0.5 M sucrose for 20 seconds. The oocytes were loaded onto grids and plunged into SN2 or liquid nitrogen (LN2). Stored oocytes 
were warmed by a five-step me thod, and then their survival, maturation, cleavage, and developmental rates were observed. 
Results: The EG only and EG+DMSO groups showed no significant difference in survival of immature oocytes vitrified after warming. Howev-
er, maturation and cleavage rates after conventional insemination were greater in the EG only group than in the EG+DMSO group. In mature 
oocytes, survival, cleavage, and blastocyst formation rates after warming showed no significant difference when EG only or EG+DMSO was ap-
plied. Furthermore, cleavage and blastocyst formation rates of MII oocytes vitrified using SN2 were increased in both the EG only and EG+DMSO 
groups. 
Conclusion: A combination of CPAs in oocyte cryopreservation could be formulated according to the oocyte stage. In addition, SN2 may im-
prove the efficiency of vitrification by reducing cryoinjury.
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Introduction
Since the first successful pregnancy derived from cryopreserved hu-
man oocytes was reported in 1986 [1,2], various freezing and thaw-
ing protocols have been applied to the cryostorage of oocytes. Oo-
cyte cryopreservation boasts various advantages over embryo cryo-
preservation. Oocyte cryopreservation would significantly contribute 
in assisted reproductive technology (ART) programs. It allows pati-
ents to cryopreserve their oocytes when they have no partner or are 
about to lose their ovarian function due to surgery, chemotherapy, or 
radiotherapy or want to delay the delivery [3]. Also, it avoids ethical 
issues and legal restrictions. Unfortunately, despite remarkable prog-
ress, oocyte cryopreservation remains a demanding task, as there is 
no precise standardization of cryopreservation and warming proce-
dures. Hence, the technique is not yet widely used in clinical practice. 
The slow cooling method was initially used for oocyte cryopreser-
vation. However, only a few studies have demonstrated successful 
outcomes of oocytes that were frozen using a slow cooling method 
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[1,2]. This can be explained by zona pellucida hardening from prema-
ture cortical granule exocytosis, chromosomal nondisjunction caused 
by serious disturbance of the microtubules, disturbance in pronuclear 
(PN) formation, and polar body release from microfilament damage 
and cytoskeleton alteration after cryopreservation [4-10]. Several stu-
dies have reported effective outcomes of applying various improved 
systems including reducing the concentration of sodium in cryopro-
tectants (CPAs) [11,12] or using different types and concentration of 
CPAs during cryopreservation [13-17]. In addition, some studies re-
ported excellent survival, embryonic development, and pregnancy 
rates by applying a vitrification method which avoids the formation 
of ice crystals using a high concentration of CPA and ultra-rapid cool-
ing speed [18]. Advantages of vitrification include that it is time-sav-
ing, easy to perform, and does not require expensive equipment. 
Most importantly, it could minimize the damage to oocytes in that it 
avoids the forming of ice crystals. However, its drawback is that it re-
quires a high concentration of CPA, which may cause toxicity and os-
motic damage to the oocyte. Since the development of vitrification, 
the toxicity of CPA has been the one of the major concerns in apply-
ing this method as a cryopreservation method. Several studies have 
been conducted to avoid the drawback by using CPA with high 
speed permeability and less toxicity or by applying a combination of 
permeable and non permeable CPAs to decrease the absolute con-
centration without a decrease in the relative concentration. Also, in 
order to increase the cooling rate for vitrification, many studies have 
been attempted for minimizing the CPA solution volume or improv-
ing the heat conductivity of cryo-equipment. Furthermore, using liq-
uid nitrogen in a slush state (slush nitrogen, SN2) has improved the 
survival and embryonic development rates after vitrification of oo-
cytes and embryos and this may be due to the increase in the heat 
transfer rate that is associated with SN2 [19,20]. 
Ethylene glycol (EG) is widely used in the vitrification method as it is 
one of the major permeable CPAs with a low molecular weight, and 
it is also less toxic to mammal oocytes or embryos including humans 
[21-24]. In particular, the strategy for reducing cell injury by applying 
a short exposure to a high concentration of CPA has been widely used. 
In contrast, Mukaida et al. [25] has recently reported a high survival 
rate of embryos that were vitrified at a blastocyst stage with a com-
bination of EG and dimethylsulfoxide (DMSO, a slow permeable CPA). 
The combination of CPAs for the vitrification process may have in-
duced a lower relative concentration and also lower toxicity of CPAs. 
In fact, as DMSO penetrates into the cell, it accelerates its characteris-
tics of glass-forming and it increases the permeability rate as it com-
bines with the other types of CPAs which complement each other. 
Also, there has been a report that when a combination of CPAs was 
used, a higher blastocyst development was obtained compared to 
using only 40% EG in bovine oocytes [26]. These studies have been 
conducted only with embryos or blastocyst stage embryos, but not 
many studies have worked with germinal vesicle (GV) stage or meta-
phase II (MII) stage oocytes. In addition, few studies have been con-
ducted regarding the cooling rate, which is one of factors that affect 
oocytes or embryos during vitrification [27]. Therefore, in this study, 
we analyzed the survival and subsequent embryonic development 
rates of immature and mature mouse oocytes after a vitrification and 
warming process using combinations of CPAs and/or using SN2 to 
develop an efficient vitrification method for immature and mature 
oocytes. 
Methods
1. Preparation of immature and mature oocytes
ICR mice (Samtako, Seoul, Korea) were maintained in a tempera-
ture-and-humidity-controlled room under a 12 hours: 12 hours light: 
dark cycle. For immature oocyte collection, four-week-old female 
mice were superovulated via an intraperitoneal injection of 5 IU preg-
nant mare serum gonadotropin (PMSG; Dae Sung Microbiological 
Labs, Seoul, Korea). At 44-46 hours post PMSG, mice were sacrificed 
by cervical dislocation for the collection of ovaries. The ovaries were 
then transferred to Quinn’s advantage medium with HEPES (Quinn’s-
HEPES; Sage, In Vitro Fertilization, Trumbull, CT, USA) containing 10% 
substitute protein serum (SPS; Sage BioPharma, Inc., Bedminster, NJ, 
USA). Immature oocytes were collected by puncturing of follicles 
with a needle (29 G). Cumulus-enclosed immature oocytes were se-
lected for the experiment. For the collection of mature oocytes, 4- 
week-old ICR female mice were superovulated with 5 IU PMSG, fol-
lowed by injection with 5 IU human chorionic gonadotropin after 48 
hours (hCG; Intervet, Boxmeer, the Netherland). Cumulus-enclosed 
mature oocytes were retrieved at 13.5-14 hours post-hCG from the 
oviducts.
 
2. Vitrification and warming of oocytes
Quinn’s-HEPES with 20% (v/v) fetal bovine serum (FBS; Gibco, Grand 
Island, NY, USA) was used as the base medium for preparation of all 
vitrification and warming solutions. As a CPA, EG (Sigma-Aldrich, St. 
Louis, MO, USA) only or a combination of EG and DMSO (Sigma-Al-
drich) were used for the vitrification procedure. For group 1, oocytes 
were pre-equilibrated with 1.5 M EG for 2.5 minutes, followed by 
equilibration with 5.5 M EG and 1.0 M sucrose for 20 seconds. For 
group 2, oocytes were pre-equilibrated with 1.3 M (7.5%) EG and 1.1 
M (7.5%) DMSO for 2.5 minutes, followed by 2.7 M (15%) EG, 2.1 M 
(15%) DMSO and 0.5 M sucrose for 20 seconds. CPA-equilibrated oo-
cytes were loaded onto an electron microscopic (EM) copper grid 
and plunged into liquid nitrogen (LN2) or SN2. SN2 was produced us-
ing a Vit-master (IMT, Ness Ziona, Israel). The concentration of CPA   doi: 10.5653/cerm.2011.38.1.24
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was determined according to the study of Mukaida et al. [25]. Vitri-
fied immature and mature oocytes were stored for at least 2 weeks 
and then warmed to compare their survival and subsequent embry-
onic development. 
The vitrified oocytes were warmed by a five-step method. The cop-
per grids were sequentially transferred to 1.0, 0.5, 0.25, 0.125, and 0 
M sucrose with an interval of 2.5 minutes. The vitrified/warmed oo-
cytes were then washed with fresh culture medium for three times. 
The immature oocytes were transferred to the culture medium and 
observed under a microscope for the survival rate of oocytes 1 hour 
after warming. The surviving immature oocytes were then induced 
to develop into mature oocytes by culturing them in the in vitro mat-
uration medium. The mature oocytes from the immature stage and 
the survived mature oocytes obtained earlier were fertilized in vitro 
for further experimentation. 
3. In vitro maturation of oocytes
Survived immature oocytes from the vitrification/warming process 
were induced for maturation in G2.3 medium (Vitrolife, Göteborg, 
Sweden) containing 20% FBS, 0.075 IU/mL FSH (Gonal-F, Serono, Mo-
dugno Bari, Italy), 0.5 IU/mL hCG (Ovidrel, Serono) and 1.0 µg/mL es-
tradiol (Sigma-Aldrich) for 14 hours. Cumulus cells from mature oo-
cytes were removed with modified Dulbecco’s phosphate-buffered 
saline (D-PBS, HyClone, South Logan, UT, USA) solution containing 
0.1% hyalurodase (Sigma-Aldrich). Denuded oocytes were washed 
with fresh culture medium three times and their maturation rate was 
then evaluated by observation of the first polar body under the mi-
croscope. 
4. In vitro fertilization and culture
Epididymal spermatozoa were obtained from 8- to 10-week-old 
male ICR mice. Sperm suspension was capacitated in the incubator 
at 37˚C, in 5% CO2 in air for 90 minutes. Capacitated spermatozoa 
were mixed (1-2×10
6/mL) with cumulus-oocyte complex in Quinn’s 
advantage fertilization medium and incubated for 6 hours. The oo-
cytes were then washed three times in modified simplex-optimized 
medium (KSOM; Millipore, Danvers, MA, USA) supplemented with 
0.3% bovine serum albumin (BSA; Sigma-Aldrich). The fertilized oo-
cytes were cultured in KSOM under 37˚C in 5% CO2 for 5 days to ana-
lyze embryonic development.
5. Statistical analyses
Survival and maturation rates of oocytes, embryonic development, 
and blastocyst formation rates were analyzed for statistical signifi-
cance with one-way ANOVA (Duncan-test). p-values<0.05 were con-
sidered statistically significant. 
Results
1. Effect of CPA on the survival, maturation, and embryonic 
development of immature oocytes after vitrification using 
LN2 or SN2
The survival and maturation rates of immature oocytes were com-
pared after the vitrification/warming process using EG only or a com-
bination of EG+DMSO as CPAs (Table 1). After vitrification/warming 
using LN2, there was no significant difference in the survival rates of 
the EG only group and the EG+DMSO group (79.8±4.7% vs. 87.9± 
1.1%; p>0.05), nor was there any difference between the groups 
when using SN2 (79.4±3.2% vs. 88.9±1.4%; p>0.05). However, the 
EG+DMSO group showed a higher maturation rate than the EG only 
group in both LN2 and SN2 (73.2±6.1%, 73.9±1.2% vs. 49.1±9.0%, 
52.3±3.4 %; p<0.05). The cleave rate of immature oocytes in the EG 
only group was significantly lower than that of the control and EG+  
DMSO groups after vitrification using LN2 (26.3±7.8% vs. 62.9±12.2% 
and 57.7±5.0%; p<0.05). After vitrification using SN2, the cleave rate 
in the EG group was lower than in the EG+DMSO group, but the dif-
ference was not statistically significant (37.4±4.8% vs. 58.8±3.7%; 
p>0.05). All groups showed a very low blastocyst formation rate. Nu-
merically, a higher rate of blastocyst formation was observed in the 
EG+ DMSO group after vitrification using SN2, than the other groups 
but it was not statistically significant (3.9±1.7% vs. 0±0.0%, 1.3±0.7%, 
1.9±1.2%; p>0.05). 
Table 1. The effect of different cryoprotectants and cooling speed generated by using LN2 or SN2 on the survival and maturation of immature 
oocytes following vitrification
Oocyte 
stage
Treatment (solution)
LN2/ SN2
No. (%) of oocytes
Pre-equilibration Equilibration Concentration Vitrified Survival (%) Maturation (%)
GV oocyte Control 124 109 (87.9±1.1)
a
1.5 M EG 5.5 M EG+1.0 M Su 5.5 M LN2 114 91 (79.8±4.7) 56 (49.1±9.0)
c
1.5 M EG 5.5 M EG+1.0 M Su 5.5 M SN2 107 85 (79.4±3.2) 56 (52.3±3.4)
c
1.3 M EG+1.1 M DMSO 2.7 M EG+2.1 M DMSO+0.5 M Su 4.8 M LN2 149 131 (87.9±1.1) 109 (73.2±6.1)
b
1.3 M EG+1.1 M DMSO 2.7 M EG+2.1 M DMSO+0.5 M Su 4.8 M SN2 153 136 (88.9±1.4) 113 (73.9±1.2)
a,b
GV, germinal vesicle; EG, ethylene glycol; DMSO, dimethylsulphoxide; Su, sucrose; LN2, liquid nitrogen; SN2, slush nitrogen.
a,b,cDifferent superscripts within the same column indicate significant differences (p<0.05).www.eCERM.org
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2. Effect of CPA on the survival, maturation, and embryonic 
development of mature oocytes after vitrification using LN2 
or SN2
Mature oocytes were vitrified and warmed as immature oocytes 
and the survival rate was evaluated (Table 2). After vitrification using 
LN2 or SN2, there was no significant difference between the survival 
rates of the EG only and EG+DMSO groups (71.0±2.4%, 75.0±3.5% 
vs. 60.0±8.8%, 79.0±4.3%; p>0.05). There were no significant dif-
ferences in cleave rates in the EG only and EG+DMSO groups after 
vitrification using LN2 or SN2 (49.0±5.9% vs. 43.0±4.5%, 59.0±1.1% 
vs. 62.0±2.6%; p>0.05). However, the cleave rate was significantly 
higher in SN2 than in LN2 in the EG only and EG+DMSO groups (59.0 
±1.1%, 62.0±2.3% vs. 49.0±5.9%, 43.0±4.5%; p<0.05). Further-
more, a higher blastocyst formation rate was observed in SN2 than in 
LN2 for the EG+DMSO group. (21.0±2.2% vs. 7.0±0.8%; p<0.05).
Discussion
Cryopreservation of immature oocytes at the GV stage was consid-
ered an alternative to avoid the drawbacks of cryopreservation of 
mature oocytes such as chromosomal nondisjunction induced by 
damage to the spindle and premature cortical granule exocytosis 
[28,29]. However, as cumulus cells and cytoplasm are tightly connect-
ed together, immature oocyte cryopreservation resulted in major 
damage and also a low maturation rate; hence, its clinical applica-
tions have been limited. Recently, the vitrification process was ap-
plied to overcome these drawbacks. In fact, in this study, a high sur-
vival rate was obtained by applying vitrification; in particular, using 
combinations of CPAs, EG, and DMSO in vitrification showed an ap-
proximately 90% survival rate (Table 1). The fertilization and cleave 
rates of oocytes were also higher in the CPA combination group. 
In many studies, the pre-equilibrium and equilibrium time were 
longer when DMSO was used for cryopreservation, as it has a lower 
permeability rate than EG [30]. Hence, we have conducted a prelimi-
nary study and compared the blastocyst formation rate of oocytes and 
embryos by using different pre-equilibrium and equilibrium times. 
As a result, there was no difference in the blastocyst formation for 
various time and, in fact, when oocytes or embryos were treated with 
DMSO with the same exposure time as to EG, they showed even bet-
ter results [31]. Consequently, unlike other studies, we used the same 
exposure time for the EG group and EG+DMSO combination group. 
Slush nitrogen was used to analyze the effect of the cooling rate. The 
Table 2. The effect of different cryoprotectants and cooling speed generated by using LN2 or SN2 on the survival and maturation of mature oo-
cytes following vitrification
Oocyte stage
Treatment (solution)
LN2/SN2
No. (%) of oocytes
Pre-equilibration Equilibration Concentration Vitrified Survival (%)
MII oocyte 1.5 M EG 5.5 M EG+1.0 M Su 5.5 M LN2 100 71 (71.0±2.4)
a
1.5 M EG 5.5 M EG+1.0 M Su 5.5 M SN2 100 75 (75.0±3.5)
a
1.3 M EG+1.1 M DMSO 2.7 M EG+2.1 M DMSO+0.5 M Su 4.8 M LN2 100 60 (60.0±8.8)
a
1.3 M EG+1.1 M DMSO  2.7 M EG+2.1 M DMSO+0.5 M Su 4.8 M SN2 100 79 (79.0±4.3)
a
MII, meta phase II; EG, ethylene glycol; DMSO, dimethylsulphoxide; Su, sucrose; LN2, liquid nitrogen; SN2, slush nitrogen.
 
aThe same superscript within the column indicates no significant differences. 
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results showed that there was no particular effect on survival, matu-
ration, or cleavage rates after warming immature oocytes (Figure 1). 
The fertilization rate showing two PN could not be identified because 
the conventional insemination method was used in this study and 
also the blastocyst formation rate was very low. These results may be 
due to the inefficiency of the vitrification/warming process or the 
possibility of side effects such as parthenogenesis. Hence, this results 
in a limitation of the study. For evaluation of the effectiveness of im-
mature oocyte cryopreservation, it is necessary to carry out further 
research using a method such as intracytoplasmic sperm injection, 
which directly injects sperm into an oocyte. Furthermore, in this study, 
only the survival and embryonic development rates were observed, 
but not intracellular changes that may occur during the vitrification/
warming process, and so the direct effect of using a combination of 
CPAs was not possible to evaluate. Hence, further study is required. 
In mature oocytes, the results obtained were different from those 
of immature oocytes. After the vitrification/warming process, the sur-
vival, cleavage, and blastocyst rates of the EG only and EG+DMSO 
groups were not significantly different (Table 2, Figure 2). However, 
when SN2 was used for vitrification, there was no significant differ-
ence in the survival rate, but it did increase the cleavage and blasto-
cyst formation rates. Also, the blastocyst formation rate was signifi-
cantly higher when a combination of CPAs, EG and DMSO, and SN2 
were used. As stated previously, this result is may be due to the in-
crease in the efficiency of vitrification by using DMSO, which acceler-
ates its glass-forming characteristics as it penetrates into the cell and 
also due to SN2, which increases the cooling rate [19,20,25]. 
From this study, we observed that adjusting an existing vitrification 
solution that is generalized worldwide is required in order to increase 
the efficiency of vitrification, as the characteristics of immature and 
mature oocytes are different. Also, although applying SN2 in vitrifica-
tion process did not affect immature oocytes, it did affect the embry-
onic development of mature oocytes after the warming process. These 
results are due to the characteristics of mature oocytes which include 
an exposed spindle that is essential for chromosomal division; how-
ever, further study is required to evaluate the mechanism in more 
detail. In this study, although the survival rate of immature oocytes 
was as high as that obtained from mature oocytes, immature oocytes 
still showed a low embryonic development rate after vitrification/
warming process. This result was similar to studies of human oocytes 
[32,33]. It is suggested that this is not only caused by problems with 
the oocyte cryopreservation process but also the lack of research on 
the in vitro maturation process. Therefore, if studies on the process of 
in vitro maturation of oocytes and development of a culture system 
move forward then the efficiency of immature oocyte cryopreserva-
tion should be expected to improve.
In conclusion, the combination of CPAs, EG, and DMSO showed 
greater effectiveness in the vitrification of immature oocytes while 
for that of mature oocytes, it is possible to use either EG only or EG 
and DMSO. In addition, SN2 may improve efficiency by reducing cryo-
injury during vitrification. 
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